ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0112

A Randomized Trial Showing No Differences in Patient Satisfaction with Telemedicine Delivered by Phone or Video During COVID-19 in Rheumatology and Other Medical Specialty Clinics

Maria I. Danila1, Dongmei Sun2, Lesley Jackson1, Gary Cutter1, Elizabeth Jackson1, Eric Ford1, Erin DeLaney1, Amy Mudano1, Jeffrey Foster1, Giovanna Rosas1, Jeffrey Curtis3 and Kenneth Saag1, 1University of Alabama at Birmingham, Birmingham, AL, 2Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, Birmingham, AL, 3Division of Clinical Immunology and Rheumatology, Department of Medicine, Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL

Meeting: ACR Convergence 2021

Keywords: Access to care, clinical trial, Patient reported outcomes

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 6, 2021

Title: Epidemiology & Public Health Poster I: COVID-19 & Vaccination (0084–0117)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: The COVID-19 pandemic has led to a significant shift to home-based telemedicine including video and phone-only visits in many medical specialties. However, patients may be agnostic about the relative value and satisfaction with one form of telemedicine compared to another. Thus, the goal of our study was to determine if patient satisfaction with phone-only visits was noninferior to video visits in rheumatology and two other medical clinics at a large tertiary referral center in the Deep South, a region which is home to many socioeconomically disadvantaged older individuals.

Methods: We conducted a parallel group, randomized (1:1), single-blind, noninferiority trial comparing satisfaction rates for two telemedicine delivery methods: phone-only (intervention group) and video visits (standard group). Adults, age >= 60 years or with public insurance (Medicare/Medicaid) were recruited from rheumatology, family medicine, cardiology clinics. The primary outcome was visit satisfaction rate (9 or 10 on a 0-10 satisfaction scale). Noninferiority was determined if satisfaction with phone-only (intervention) versus video visits (comparator) was no worse by a -15% noninferiority margin. We performed modified intent-to-treat (mITT) and per protocol analysis. We also examined preference for the next visit type, whether patient concerns were addressed during the visit, and whether patients recommended telemedicine.

Results: A total of 200 participants (87.3%), including 96 assigned to video group and 104 assigned to phone-only group, completed surveys on average 2.7 (3.4) days post-visit. A third of the participants were recruited from the rheumatology clinic. This population defines the modified intent-to-treat (mITT) analysis. Overall, participants who completed the surveys were predominately women (N=136, 68%), 86 (43%) were Black with a mean age in the early sixties consistent with the inclusion criteria, and the majority had at least some college education (N=148, 74%) (Table 1).The satisfaction rates were higher than anticipated in both groups (78.1% for video vs 84.6% for phone-only) and not significantly different, (p = 0.32) (Table 2). In the mITT analysis, phone-only visits were noninferior by an adjusted difference of 3.2% (95% CI, -7.6% to 14%). In the per protocol analysis, phone-only were noninferior by an adjusted difference of -4.1% (95% CI, -14.8% to 6.6%) (Figure 1). The proportion of participants who indicated they preferred the same type of telemedicine visit as their next clinic visit were similar (30.2% versus 27.9% video versus phone-only group, p = 0.78) and a majority said their medical concerns were addressed and would recommend a telemedicine visit.

Conclusion: Among a group of diverse, medically at-risk patients seen in rheumatology and two other medical clinics the satisfaction rate for phone-only was noninferior to video visits. Our findings provide added data on patients’ acceptance and satisfaction with different types of telemedicine in populations of concern, which can inform clinical, regulatory, and administrative context of telemedicine and related reimbursement policies for medical care of patients with chronic diseases during and beyond the COVID-19 era.

Table 1

Table 2

Figure 1


Disclosures: M. Danila, Boehringer Ingelheim, 5, Amgen, 1, Amgen, 5, AbbVie, 1, Pfizer, 5, Pfizer, 11, Horizon, 5, Novartis, 1, WebMD, 12, writer; D. Sun, None; L. Jackson, None; G. Cutter, Mitsubishi Tanabe Holdings DSMB, 1, Clinical Trial Solutions LLC, 2; E. Jackson, Amgen, 5, Uptodate, 9, McKesson, 2; E. Ford, None; E. DeLaney, None; A. Mudano, None; J. Foster, None; G. Rosas, None; J. Curtis, AbbVie, 2, Amgen, 2, 5, Bristol-Myers Squibb, 2, Janssen, 2, Eli Lilly, 2, Myriad, 2, Pfizer Inc, 2, 5, Roche/Genentech, 2, UCB, 2, CorEvitas, 2, 5, Crescendo Bio, 5; K. Saag, Arthrosi, 2, Atom Bioscience, 2, Horizon Therapeutics, 2, 5, LG Pharma, 2, Mallinkrodt, 2, SOBI, 2, 5, Takeda, 2, Shanton, 5.

To cite this abstract in AMA style:

Danila M, Sun D, Jackson L, Cutter G, Jackson E, Ford E, DeLaney E, Mudano A, Foster J, Rosas G, Curtis J, Saag K. A Randomized Trial Showing No Differences in Patient Satisfaction with Telemedicine Delivered by Phone or Video During COVID-19 in Rheumatology and Other Medical Specialty Clinics [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/a-randomized-trial-showing-no-differences-in-patient-satisfaction-with-telemedicine-delivered-by-phone-or-video-during-covid-19-in-rheumatology-and-other-medical-specialty-clinics/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-randomized-trial-showing-no-differences-in-patient-satisfaction-with-telemedicine-delivered-by-phone-or-video-during-covid-19-in-rheumatology-and-other-medical-specialty-clinics/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology